Pulmonary Hypertension Machine Learning-Based Notification Software
SAT is the FDA product code for Pulmonary Hypertension Machine Learning-Based Notification Software, a class II device type, regulated under 21 CFR 870.2380. FDA's definition for this code reads: "Pulmonary hypertension machine learning-based notification software employs machine learning techniques to suggest the likelihood of pulmonary hypertension for further referral or diagnostic follow-up". As of , FDA records hold 3 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- SAT
- Device name
- Pulmonary Hypertension Machine Learning-Based Notification Software
- FDA definition
- Pulmonary hypertension machine learning-based notification software employs machine learning techniques to suggest the likelihood of pulmonary hypertension for further referral or diagnostic follow-up.
- Regulation
- 21 CFR 870.2380
- Device class
- Class II
- Review panel
- Cardiovascular
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 3
- Ingested recalls
- 0
Clearances, product code SAT
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2024 | 1 |
| 2026 | 2 |
Applicants with the most clearances
Product code SAT| Applicant | Clearances |
|---|---|
| Analytics for Life Inc. | 1 |
| Anumana Inc. | 1 |
| Tempus AI, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
